Design Therapeutics Stock (NASDAQ: DSGN) stock price, news, charts, stock research, profile.
Open | $4.11 |
Close | $4.07 |
Volume / Avg. | 63.93K / 216.33K |
Day Range | 4.00 - 4.12 |
52 Wk Range | 1.94 - 8.31 |
Market Cap | $229.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 11.61% |
Days to Cover | 14.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.
Other companies in Design Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), Tectonic Therapeutic (NASDAQ:TECX), Renovaro (NASDAQ:RENB) and bluebird bio (NASDAQ:BLUE).
There is no analysis for Design Therapeutics.
Design Therapeutics has a consensus price target of $6.75.
The stock price for Design Therapeutics (NASDAQ: DSGN) is $4.07 last updated July 19, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Design Therapeutics.
Design Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Design Therapeutics.
Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.